Babo Yohannes Demissie, Alemie Getahun Asres, Fentaye Fasil Walelign
Management Science for Health, Bahirdar, Ethiopia.
Public Health Institute, College of Medicine & Health Sciences, University of Gondar, Gondar, Ethiopia.
PLoS One. 2017 Nov 2;12(11):e0187694. doi: 10.1371/journal.pone.0187694. eCollection 2017.
Due to the limited availability of viral load testing for treatment outcome monitoring in resource limited settings, identifying predictive factors of antiretroviral treatment failure will help in selecting clients who will benefit most from the targeted use of viral load monitoring. Little is known about the predictors of treatment failure in the study area. This study was conducted to determine factors that predict first-line antiretroviral therapy failure among HIV-infected adult clients at Woldia Hospital, Northeast Ethiopia. For this study, antiretroviral therapy treatment failure was defined as the fulfillment of clinical and/or immunological criteria set by WHO.
Case-control study was carried out from November to December 2014. Cases were adult clients who were on failing first line regimen and on active follow up while controls were those adult clients on a non-failing first-line regimen for 36 months and above and on active follow up. Data was entered in to Epi Info version 7 and was exported to SPSS version 20 for analysis. Binary logistic regression model was used to identify predictors of ART failure.
A total of 59 cases and 245 controls were included in the analysis. Sixty three percent of the participants were females and the median age at ART enrollment was 33 years (IQR; 28, 40). The median baseline CD4count was not significantly different among cases and controls (105 (IQR = 60-174)vs.131 (IQR = 72.5-189.0); p = 0.301). The median peak CD4 count in the failure group (230 (IQR = 123-387)) was significantly low compared to the non-failure group (463 (IQR = 348.5-577)) [p < 0.001]. High peak CD4count (AOR = 0.993; 95% CI 0.990, 0.996) and longer duration on ART (AOR = 0.923; 95% CI 0.893, 0.954) were protective of treatment failure. In addition stavudine based regimen (AOR = 3.47; 95% CI 1.343, 10.555), low baseline BMI (AOR = 2.75; 95% CI 1.012, 7.457), unemployment (AOR = 4.93; 95% CI 1.493, 16.305) and formal educational level (AOR = 5.15; 95% CI 1.534, 17.276) were independently significant predictors of treatment failure.
In this setting low peak CD4count, shorter duration on first line ART, d4T based regimen, low baseline BMI, unemployment and formal educational level were significantly associated with increased treatment failure. Retaining patients on their initial first line regimen with appropriate follow up and improving their socioeconomic status through various livelihood initiatives should be strengthened.
由于在资源有限的环境中,用于治疗效果监测的病毒载量检测的可用性有限,确定抗逆转录病毒治疗失败的预测因素将有助于选择那些将从有针对性地使用病毒载量监测中获益最大的患者。关于研究地区治疗失败的预测因素知之甚少。本研究旨在确定埃塞俄比亚东北部沃尔迪亚医院感染艾滋病毒的成年患者中一线抗逆转录病毒治疗失败的预测因素。在本研究中,抗逆转录病毒治疗失败被定义为符合世界卫生组织设定的临床和/或免疫学标准。
于2014年11月至12月进行病例对照研究。病例为正在接受失败的一线治疗方案且正在积极随访的成年患者,而对照为接受非失败的一线治疗方案36个月及以上且正在积极随访的成年患者。数据录入Epi Info 7版本,并导出到SPSS 20版本进行分析。采用二元逻辑回归模型确定抗逆转录病毒治疗失败的预测因素。
共有59例病例和245例对照纳入分析。63%的参与者为女性,开始接受抗逆转录病毒治疗时的中位年龄为33岁(四分位间距;28,40)。病例组和对照组的基线CD4细胞计数中位数无显著差异(105(四分位间距=60 - 174)对131(四分位间距=72.5 - 189.0);p = 0.301)。失败组的CD4细胞计数峰值中位数(230(四分位间距=123 - 387))显著低于非失败组(463(四分位间距=348.5 - 577))[p < 0.001]。较高的CD4细胞计数峰值(比值比=0.993;95%置信区间0.990,0.996)和较长的抗逆转录病毒治疗持续时间(比值比=0.923;95%置信区间0.893,0.954)对治疗失败有保护作用。此外,基于司他夫定的治疗方案(比值比=3.47;95%置信区间1.343,10.555)、低基线体重指数(比值比=2.75;95%置信区间1.012,7.457)、失业(比值比=4.93;95%置信区间1.493,16.305)和正规教育水平(比值比=5.15;95%置信区间1.534,17.276)是治疗失败的独立显著预测因素。
在这种情况下,较低的CD4细胞计数峰值、较短的一线抗逆转录病毒治疗持续时间、基于司他夫定的治疗方案、低基线体重指数、失业和正规教育水平与治疗失败增加显著相关。应加强让患者坚持其初始一线治疗方案并进行适当随访,并通过各种生计举措改善他们的社会经济状况。